Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2003

View Archived Issues

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Alpha Therapeutic receives FDA approval for Aralast

Neurogen presents novel CRF1 modulators for anxiety, depression, IBS, etc.

Novel factor Xa inhibitors and their use covered by Millennium patent

NeuroSearch claims dual modulators of nicotinic receptors and monoamine transporters

New glycogen phosphorylase inhibitors discovered by Aventis researchers

AstraZeneca describes a nicotinic acetylcholine alpha7 agonist with cognition-enhancing properties

Novel series of adenosine A3 antagonists in early development at Sanofi-Synthelabo

Vertex scientists report inhibitors of GSK-3, Aurora-2 and Syk kinases

Captopril-allicin hybrids with antihypertensive and lipid- and insulin-lowering activity

Cyberonics reports one-year data from depression study

FDA committee discusses Replagal for Fabry's disease

Fabrazyme discussed by FDA advisory committee

Phase II trial of Advexin plus radiation shows tumor regression in NSCLC

Access licenses amlexanox to Zambon

Effect of AGI-1067 on atherosclerosis assessed in pivotal trial

Corixa and IDRI begin phase I trial of leishmaniasis vaccine

Phase II trial of MC-1 meets primary and secondary endpoints

Pain Therapeutics and Durect sign agreement to formulate long-acting opioid drugs

Preclinical antitumor profile of ST-1481, a new camptothecin derivative

Inhibition of COX-2 as a novel therapeutic option for acute pancreatitis

Strattera launched in the U.S.

Caelyx approved in E.U. for metastatic breast cancer

GSK launches Avodart for BPH in U.S.

FDA temporarily halts gene therapy trials using retroviral vectors in blood stem cells

Fujisawa and Sankyo form business arrangement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...